Related Experiment Video
Updated: Feb 27, 2026

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mast cell, pro-inflammatory and anti-inflammatory: Jekyll and Hyde, the story continues
P Conti1, Al Caraffa2, S K Kritas3
1Immunology Division, Postgraduate Medical School, University of Chieti, Chieti, Italy.
Insights
This study compares interleukin-10 (IL-10) and interleukin-37 (IL-37), two anti-inflammatory cytokines. Both IL-10 and IL-37 effectively inhibit mast cell inflammatory cytokines in various conditions.
Area of Science:
- Immunology
- Cytokine Biology
Background:
- Mast cells (MCs) are key immune cells involved in inflammation, allergy, and cancer.
- MCs release pro-inflammatory mediators and are regulated by cytokines like IL-10.
- Interleukin-1 family members exhibit diverse roles in both inflammation and anti-inflammation.
Discussion:
- Interleukin-10 (IL-10) is a pleiotropic cytokine that suppresses Th1 inflammatory responses and inhibits cytokines like TNF, IFN-γ, IL-1, and IL-6.
- Interleukin-37 (IL-37), a newer family member, binds the IL-18 receptor α chain and inhibits inflammatory mediators including TNF, IL-1, IL-6, IL-33, and nitric oxide.
- Both IL-10 and IL-37 demonstrate inhibitory effects on mast cell-derived inflammatory cytokines.
Key Insights:
- IL-37 shares functional similarities with IL-10 in suppressing mast cell-driven inflammation.
- The study provides a comparative analysis of these two critical anti-inflammatory cytokines.
- Both cytokines show potential therapeutic relevance in inflammatory disorders and cancer.
Outlook:
- Further research is warranted to elucidate the precise mechanisms and therapeutic applications of IL-37 compared to IL-10.
- Investigating the synergistic or differential effects of IL-10 and IL-37 could reveal novel treatment strategies.
- Understanding these cytokine interactions is crucial for managing inflammatory conditions and cancer.
Abstract:
IL-1 family members include inflammatory and anti-inflammatory cytokines. They can be beneficial or detrimental, not only in cancer, but also in inflammatory conditions. Mast cells (MCs) originate from CD34+/CD117+/CD13+ pluripotent hematopoietic stem cells, express c-Kit receptor (c-Kit-R), which regulates the proliferation and sustain the survival, differentiation and maturation of MCs. They are immune cells involved in innate and adaptive immunity, allergy, autoimmunity, cancer and inflammation. MCs along with T cells and macrophages release interleukin (IL)-10, which is a pleiotropic immunoregulatory cytokine with multiple biological effects. IL-10 inhibits Th1 inflammatory cells, in particular TNF mostly generated by macrophages and MCs, and down-regulates IFN-γ, IL-1 and IL-6. IL-37 is a family member cytokine which binds IL-18 receptor α chain and inhibits inflammatory mediators including TNF, IL-1, IL-6, IL-33 and nitric oxide (NO). IL-37 similar to IL-10 inhibits MC inflammatory cytokines in several disorders, including asthma, allergy, arthrtitis and cancer. Here we report a study comparing IL-10 with IL-37, two anti-inflammatory cytokines.
Related Concept Videos
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Differentiation of Common Myeloid Progenitor Cells
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Response I: Vascular and Cellular

